Evidence map›Paper›PMID 29891545›Full record

ArticleInfection and immunity2018

Identification of Mycobacterial Ribosomal Proteins as Targets for CD4

Steven C Kennedy, Alison J Johnson, Sushma Bharrhan, Cecilia S Lindestam Arlehamn, Jiayong Xu, Scott J Garforth, John Chan, William R Jacobs, Alessandro Sette, Steven C Almo and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. HigB1 Toxin inFrontiers in microbiology · 2021
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Steven C KennedyDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Alison J JohnsonDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Sushma BharrhanDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Cecilia S Lindestam ArlehamnDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Jiayong XuDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Scott J GarforthDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
John ChanDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
William R JacobsDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Alessandro SetteDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Steven C AlmoDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
Steven A PorcelliDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA steven.porcelli@einstein.yu.edu.
Albert Einstein College of Medicine · USHoward Hughes Medical Institute · USLa Jolla Institute for Immunology · USUniversity of California, San Diego · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
"The Tuberculous Granuloma"P01AI063537 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI JACOBS, WILLIAM ROBERT · 2005 to 2015
$15.7M
Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
Vaccines for Extensively Drug Resistant TuberculosisR01AI098925 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JACOBS, WILLIAM ROBERT · 2012 to 2016
$5.8M
MOLECULAR PATHOGENESIS OF INFECTIOUS DISEASEST32AI007506 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2012
$3.7M
Construction of safe and effective live tuberculosis vaccinesR01AI093649 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PORCELLI, STEVEN A · 2011 to 2015
$2.1M
NCI NIH HHS P30 CA013330NIAID NIH HHS HHSN272200900044CNIAID NIH HHS P01 AI063537NIAID NIH HHS R01 AI093649NIAID NIH HHS R01 AI098925NIAID NIH HHS T32 AI007501NIAID NIH HHS T32 AI007506
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntigens, BacterialBacterial ProteinsBCG VaccineCD4-Positive T-LymphocytesFemaleImmunization, SecondaryInterferon-gammaLungMiceMice, Inbred BALB CMycobacterium tuberculosisPeptide LibraryRibosomal ProteinsTuberculosisTuberculosis VaccinesAntigens, BacterialBacterial ProteinsBCG VaccineInterferon-gammaPeptide LibraryRibosomal ProteinsTuberculosis VaccinesantigencrypticmycobacteriologyribosomeT cellstuberculosistuberculosis vaccines

Identifiers

PMID29891545
PMCPMC6105890
OpenAlexW2807785645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.